Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+8.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Cash & Current Investments (2010 - 2026)

Updated

Citius Pharmaceuticals' Cash & Current Investments came in at $17.01 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 179.3% from $6.09 million a year earlier and up 270.5% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Cash & Current Investments was $4.25 million, up 30.8% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
  • Going back by fiscal year, Cash & Current Investments was $3.25 million in FY2024 (-87.7%), $26.48 million in FY2023 (-36.5%), $41.71 million in FY2022 (-40.5%) and $70.07 million in FY2021 (+405.6%).
  • The fiscal Q3 2026 figure represents the highest quarterly Cash & Current Investments since fiscal Q3 2024.
  • Year-over-year, Cash & Current Investments increased in three of the last seven quarters, with growth averaging 66.3%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in fiscal Q1 2026 (growth of 601.9%), and the weakest in fiscal Q2 2025 (a decline of 99.8%).
  • Business Quant data shows CTXR's Cash & Current Investments at $4.59 million (Q2 2026), $7.72 million (Q1 2026) and $4.25 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Citius Pharmaceuticals 10.98 Mn -13.30 Mn 1.00 Mn 17.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.01 Mn
Mar 31, 2026 4.59 Mn
Dec 31, 2025 7.72 Mn
Sep 30, 2025 4.25 Mn
Jun 30, 2025 6.09 Mn
Mar 31, 2025 26,410.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 3.25 Mn
Jun 30, 2024 17.91 Mn
Mar 31, 2024 12.56 Mn
Dec 31, 2023 20.35 Mn
Sep 30, 2023 26.48 Mn
Jun 30, 2023 33.28 Mn
Mar 31, 2023 29.07 Mn
Dec 31, 2022 36.89 Mn
Sep 30, 2022 41.71 Mn
Jun 30, 2022 48.04 Mn
Mar 31, 2022 55.76 Mn
Dec 31, 2021 65.42 Mn
Sep 30, 2021 70.07 Mn
API Access

Citius Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CTXR&period=max&api_key=YOUR_API_KEY